APA (7th ed.) Citation

Zhang, X., Zhou, F., Lu, T., Zhang, S., Wei, X., Qiu, X., . . . Zhuang, J. (2025). Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer. World Journal of Urology, 43(1), . https://doi.org/10.1007/s00345-024-05412-4

Chicago Style (17th ed.) Citation

Zhang, Xuyu, Feng Zhou, Tong Lu, Shun Zhang, Xuedong Wei, Xuefeng Qiu, Linfeng Xu, Hongqian Guo, and Junlong Zhuang. "Neoadjuvant Darolutamide Plus Androgen Deprivation Therapy for High-risk and Locally Advanced Prostate Cancer." World Journal of Urology 43, no. 1 (2025). https://doi.org/10.1007/s00345-024-05412-4.

MLA (9th ed.) Citation

Zhang, Xuyu, et al. "Neoadjuvant Darolutamide Plus Androgen Deprivation Therapy for High-risk and Locally Advanced Prostate Cancer." World Journal of Urology, vol. 43, no. 1, 2025, https://doi.org/10.1007/s00345-024-05412-4.